Zai Lab Limited's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 5.43, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2026. Average receivable collection period, for the Zai Lab Limited in Mar 31 2026 quarter, has decreased to 67 days, compared to 71 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 320 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1996, from overall ranking in the fourth quarter 2025 at 2098.

What is Receivable Turnover Ratio?
What is Zai Lab Limited Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ZLAB Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-29.37 %	24.58 %	70.86 %	27.09 %	26.7 %
Y / Y Revenue Change	-6.46 %	16.99 %	13.52 %	9.43 %	22.19 %
Receivable Turnover Ratio (TTM)	5.43	5.16	5.26	5.7	5.95
ZLAB's Total Ranking	# 1996	# 2098	# 2230	# 2145	# 2156
Accounts Receivable average collection period days	67	71	69	64	61
Seq. Receivable Change	-49.05 %	24.29 %	-3.53 %	15.6 %	-10.12 %
Seq. Revenue Change	-21.93 %	9.91 %	5.56 %	3.28 %	-2.37 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 93
Healthcare Sector	# 321
Overall Market	# 1996

Receivable Turnover Ratio Statistics
High	Average	Low
0.39	0.23	0
(Mar 31 2026)		(Dec 31 2018)

ZLAB Company Profile • Back to ZLAB Efficiency Comparisons • Compare ZLAB Receivables Turnover Ratio to its Competitors

Financial Statements
Zai Lab Limited's Accounts Receivable	$ 54 Millions	Visit ZLAB's Balance sheet
Zai Lab Limited's Sales TTM	$ 453 Millions	Visit ZLAB's Income Statement
Sources of ZLAB's Revenues		Visit ZLAB's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ZLAB's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ZLAB's Growth Rates	ZLAB's Roa	ZLAB's Inventory Turnover Ratio	ZLAB's Dividend Comparisons
ZLAB's Profitability Ratios	ZLAB's Roi	ZLAB's Asset Turnover Ratio	ZLAB's Dividend Growth
ZLAB's Valuation Ratios	ZLAB's Roe	ZLAB's Financial Strength Ratios	ZLAB's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Siga Technologies Inc	22.41	$ 93.777 Millions	$ 4.186 Millions
Lipocine Inc	22.09	$ 2.002 Millions	$ 0.091 Millions
Fonar Corporation	21.15	$ 105.338 Millions	$ 4.981 Millions
Neuraxis Inc	20.94	$ 4.282 Millions	$ 0.204 Millions
Vystar Corporation	20.58	$ 0.048 Millions	$ 0.002 Millions
Lifemd Inc	19.91	$ 177.869 Millions	$ 8.934 Millions
Longeveron Inc	19.07	$ 1.216 Millions	$ 0.064 Millions
Sonida Senior Living Inc	18.82	$ 411.850 Millions	$ 21.878 Millions
Nutriband Inc	16.79	$ 1.803 Millions	$ 0.107 Millions
Bioadaptives Inc	16.64	$ 0.024 Millions	$ 0.001 Millions
Premier Air Charter Holdings Inc	16.33	$ 33.205 Millions	$ 2.033 Millions
Bioage Labs Inc	15.90	$ 10.316 Millions	$ 0.649 Millions
Escalon Medical Corp	15.15	$ 11.445 Millions	$ 0.756 Millions
Nurix Therapeutics Inc	15.11	$ 71.779 Millions	$ 4.750 Millions
Rosecliff Acquisition Corp I	15.05	$ 23.433 Millions	$ 1.557 Millions
Lexicon Pharmaceuticals Inc	14.91	$ 69.643 Millions	$ 4.670 Millions
Qhslab Inc	14.80	$ 2.775 Millions	$ 0.188 Millions
Nexgel Inc	14.19	$ 10.382 Millions	$ 0.732 Millions
Sutro Biopharma Inc	14.04	$ 99.608 Millions	$ 7.095 Millions
Precipio inc	13.93	$ 25.831 Millions	$ 1.854 Millions
China Pharma Holdings Inc	13.86	$ 3.992 Millions	$ 0.288 Millions
Talkspace Inc	13.67	$ 239.269 Millions	$ 17.501 Millions
Marpai Inc	13.59	$ 17.125 Millions	$ 1.261 Millions
Amneal Pharmaceuticals Inc	13.56	$ 3,045.530 Millions	$ 224.634 Millions
Corcept Therapeutics Inc	13.20	$ 769.096 Millions	$ 58.264 Millions
Xoma Royalty Corporation	13.05	$ 48.555 Millions	$ 3.720 Millions
Mannkind Corporation	13.00	$ 360.783 Millions	$ 27.757 Millions
Lifestance Health Group Inc	12.74	$ 1,494.791 Millions	$ 117.296 Millions
Chemed Corporation	12.73	$ 2,540.548 Millions	$ 199.626 Millions
Milestone Scientific Inc	12.69	$ 8.337 Millions	$ 0.657 Millions

Date modified: 2026-07-07T14:27:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.